Literature DB >> 29031045

Structural characterization of the Man5 glycoform of human IgG3 Fc.

Ishan S Shah1, Scott Lovell2, Nurjahan Mehzabeen2, Kevin P Battaile3, Thomas J Tolbert4.   

Abstract

Immunoglobulin G (IgG) consists of four subclasses in humans: IgG1, IgG2, IgG3 and IgG4, which are highly conserved but have unique differences that result in subclass-specific effector functions. Though IgG1 is the most extensively studied IgG subclass, study of other subclasses is important to understand overall immune function and for development of new therapeutics. When compared to IgG1, IgG3 exhibits a similar binding profile to Fcγ receptors and stronger activation of complement. All IgG subclasses are glycosylated at N297, which is required for Fcγ receptor and C1q complement binding as well as maintaining optimal Fc conformation. We have determined the crystal structure of homogenously glycosylated human IgG3 Fc with a GlcNAc2Man5 (Man5) high mannose glycoform at 1.8Å resolution and compared its structural features with published structures from the other IgG subclasses. Although the overall structure of IgG3 Fc is similar to that of other subclasses, some structural perturbations based on sequence differences were revealed. For instance, the presence of R435 in IgG3 (and H435 in the other IgG subclasses) has been implicated to result in IgG3-specific properties related to binding to protein A, protein G and the neonatal Fc receptor (FcRn). The IgG3 Fc structure helps to explain some of these differences. Additionally, protein-glycan contacts observed in the crystal structure appear to correlate with IgG3 affinity for Fcγ receptors as shown by binding studies with IgG3 Fc glycoforms. Finally, this IgG3 Fc structure provides a template for further studies aimed at engineering the Fc for specific gain of function.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fc receptor; Glycosylation; High mannose; Immunoglobulin G; X-ray crystal structure

Mesh:

Substances:

Year:  2017        PMID: 29031045      PMCID: PMC5694352          DOI: 10.1016/j.molimm.2017.10.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  57 in total

1.  Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding.

Authors:  W L Martin; A P West; L Gan; P J Bjorkman
Journal:  Mol Cell       Date:  2001-04       Impact factor: 17.970

2.  High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.

Authors:  Andrew M Goetze; Y Diana Liu; Zhongqi Zhang; Bhavana Shah; Edward Lee; Pavel V Bondarenko; Gregory C Flynn
Journal:  Glycobiology       Date:  2011-03-18       Impact factor: 4.313

3.  Flexibility of human IgG subclasses.

Authors:  K H Roux; L Strelets; T E Michaelsen
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

4.  Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity.

Authors:  S Giuntini; D M Granoff; P T Beernink; O Ihle; D Bratlie; T E Michaelsen
Journal:  Clin Vaccine Immunol       Date:  2016-08-05

5.  Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.

Authors:  M H Tao; S L Morrison
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris.

Authors:  Byung-Kwon Choi; Shannon Warburton; Heping Lin; Rohan Patel; Istvan Boldogh; Michael Meehl; Meehl Meehl; Marc d'Anjou; Liza Pon; Terrance A Stadheim; Natarajan Sethuraman
Journal:  Appl Microbiol Biotechnol       Date:  2012-05-10       Impact factor: 4.813

8.  Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines.

Authors:  Amy W Chung; Musie Ghebremichael; Hannah Robinson; Eric Brown; Ickwon Choi; Sophie Lane; Anne-Sophie Dugast; Matthew K Schoen; Morgane Rolland; Todd J Suscovich; Alison E Mahan; Larry Liao; Hendrik Streeck; Charla Andrews; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Mark S de Souza; Jaranit Kaewkungwal; Punnee Pitisuttithum; Donald Francis; Nelson L Michael; Jerome H Kim; Chris Bailey-Kellogg; Margaret E Ackerman; Galit Alter
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

Review 9.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

Review 10.  IgG subclasses and allotypes: from structure to effector functions.

Authors:  Gestur Vidarsson; Gillian Dekkers; Theo Rispens
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

View more
  7 in total

1.  Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Authors:  Apurva S More; Ronald T Toth; Solomon Z Okbazghi; C Russell Middaugh; Sangeeta B Joshi; Thomas J Tolbert; David B Volkin; David D Weis
Journal:  J Pharm Sci       Date:  2018-05-08       Impact factor: 3.534

Review 2.  A synopsis of recent developments defining how N-glycosylation impacts immunoglobulin G structure and function.

Authors:  Yoshiki Yamaguchi; Adam W Barb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

3.  A stable engineered human IgG3 antibody with decreased aggregation during antibody expression and low pH stress.

Authors:  Seiji Saito; Hiroshi Namisaki; Keiko Hiraishi; Nobuaki Takahashi; Shigeru Iida
Journal:  Protein Sci       Date:  2019-03-22       Impact factor: 6.725

4.  Human immunoglobulin G hinge regulates agonistic anti-CD40 immunostimulatory and antitumour activities through biophysical flexibility.

Authors:  Xiaobo Liu; Yingjie Zhao; Huan Shi; Yan Zhang; Xueying Yin; Mingdong Liu; Huihui Zhang; Yongning He; Boxun Lu; Tengchuan Jin; Fubin Li
Journal:  Nat Commun       Date:  2019-09-27       Impact factor: 14.919

5.  Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer.

Authors:  Marta Wieczorek; Elena Ioana Braicu; Leticia Oliveira-Ferrer; Jahid Sehouli; Véronique Blanchard
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

6.  Staphylococcal protein A inhibits complement activation by interfering with IgG hexamer formation.

Authors:  Ana Rita Cruz; Maurits A den Boer; Jürgen Strasser; Seline A Zwarthoff; Frank J Beurskens; Carla J C de Haas; Piet C Aerts; Guanbo Wang; Rob N de Jong; Fabio Bagnoli; Jos A G van Strijp; Kok P M van Kessel; Janine Schuurman; Johannes Preiner; Albert J R Heck; Suzan H M Rooijakkers
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

Review 7.  Beyond Allotypes: The Influence of Allelic Diversity in Antibody Constant Domains.

Authors:  Annmaree K Warrender; William Kelton
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.